scholarly journals Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study

2012 ◽  
Vol 47 (12) ◽  
pp. 1342-1351 ◽  
Author(s):  
Takumi Kawaguchi ◽  
Atsumasa Komori ◽  
Masataka Seike ◽  
Shigetoshi Fujiyama ◽  
Hiroshi Watanabe ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Chronic Liver ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Phase

scholarly journals Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study

2018 ◽  
Vol 105 ◽  
pp. 114-126 ◽  
Author(s):  
Kenjiro Namikawa ◽  
Yoshio Kiyohara ◽  
Tatsuya Takenouchi ◽  
Hisashi Uhara ◽  
Hiroshi Uchi ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Advanced Melanoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Multicentre Phase

A multicenter open-label phase II study of the efficacy and safety of palbociclib a cyclin-dependent kinases 4 and 6 inhibitor in patients with recurrent ovarian cancer.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 5557-5557 ◽  
Author(s):  
Gottfried E. Konecny ◽  
Andrea Elisabeth Wahner Hendrickson ◽  
Aminah Jatoi ◽  
Jill K. Burton ◽  
Jill Paroly ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Recurrent Ovarian Cancer ◽  
Efficacy And Safety ◽  
Open Label ◽  
Cyclin Dependent Kinases ◽  
Open Label Phase

A multicenter, open label, phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e20044-e20044
Author(s):  
Simone M. Goldinger ◽  
Sharon Gobbi ◽  
Michelle Ding ◽  
Anna Lisa Frauchiger ◽  
Regina Fink-Puches ◽  
...  
Keyword(s):  
T Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Phase

Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome

2017 ◽  
Vol 69 (8) ◽  
pp. 1679-1688 ◽  
Author(s):  
Juan I. Arostegui ◽  
Jordi Anton ◽  
Inmaculada Calvo ◽  
Angel Robles ◽  
Estibaliz Iglesias ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Periodic Fever ◽  
Periodic Fever Syndrome ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document